neurology
ALS Functional Rating Scale (ALSFRS-R)
Assesses functional decline in ALS/MND across 12 domains. Serial scores track progression rate and guide intervention timing (PEG, NIV).
References
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Riluzole · Neuroprotective Agent — ALS/Motor Neurone Disease
- Methotrexate (Dermatology — Psoriasis) · Disease-Modifying Antirheumatic / Immunosuppressant
- Acetazolamide (Ménière's Disease) · Carbonic Anhydrase Inhibitor (Diuretic)
- Zinc acetate · Zinc salt (Wilson's disease)
- Sulfasalazine · Aminosalicylate / Disease-Modifying Antirheumatic Drug (DMARD)
- Hydroxycarbamide (Hydroxyurea) · Cytoreductive agent / Sickle cell disease / CML
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Acute Stroke Management · NICE NG128 / RCP 2023
- TIA Assessment (ABCD2) · NICE NG128 / NICE CG68
- Bacterial Meningitis (Adults) · NICE CG102 / BIA 2016
- Parkinson's Disease Management · NICE NG71 2017
Decision support only — verify against MDCalc, NICE, or your local guideline before clinical use.